PFS (n = 76) | OS (n = 110) | |||
Covariate | Univariate | Multivariate* | Univariate | Multivariate* |
Total applied activity/1,000-MBq increase | 0.84 (0.77–0.91) | 0.87 (0.79–0.95) | 0.83 (0.77–0.90) | 0.83 (0.76–0.90) |
Age at diagnosis/10-y increase | 1.11 (0.86–1.44) | 1.08 (0.79–1.47) | 1.29 (1.00–1.66) | 1.47 (1.07–2.00) |
WHO grade I | Reference | Reference | Reference | Reference |
WHO grade II | 9.06 (2.85–28.80) | 8.09 (1.50–26.11) | 2.45 (1.05–5.72) | 2.32 (0.95–5.63) |
WHO grade III | 31.17 (8.50–114.34) | 25.78 (6.76–98.40) | 4.61 (1.78–11.95) | 2.28 (0.78–6.72) |
Unknown grade | NA† | NA† | 2.58 (0.86–7.71) | 2.45 (0.73–8.24) |